| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10941026 | Immunobiology | 2013 | 6 Pages |
Abstract
Taken together, the novel, nonradioactive, CFDA-based assay was a robust tool to monitor the antileukemic immune response after DLT in myeloid leukemias.
Keywords
PBMCsMNCsIMDMMACSELISPOTDLTMoAbsSCFGM-CSFCFDAAML3H-TdRFACSGVLEPOCMLAPCE:TIscove's modified Dulbecco's mediumallophycocyaninerythropoietinAllo-HSCTEnzyme-linked immunospotFlow Cytometry Analysistritiated thymidineperipheral blood mononuclear cellsMononuclear cellsgranulocyte-macrophage colony-stimulating factorgranulocyte colony-stimulating factorStem Cell FactorG-CSFphycoerythrinFlow cytometryGraft-versus-leukemiaacute myeloid leukemiaChronic myeloid leukemiamagnetic cell sortingMonoclonal antibodiesAllogeneic hematopoietic stem cell transplantation
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Ting Yang, Zhi-zhe Chen, Hans-Jochem Kolb, Raymund Buhmann,